3 Groundbreaking Ways Researchers are Rethinking Alzheimer’s Disease

Johnson & Johnson
November 2017
Rethinking Alzheimers Disease
Diagnostic tests. Clinical trials. A vaccine. For Alzheimer’s Awareness Month, we sat down with scientists at Janssen Research & Development to learn how their work has the potential to alter the future of how we detect and treat the disease.
Tagged with: , ,